Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai
- Conditions
- COVID-19
- Registration Number
- NCT05422963
- Lead Sponsor
- Ruijin Hospital
- Brief Summary
This study is to clarify the clinical characteristics of severe and critical COVID-19 from March 1st ,2022 to June 9th, 2022 in Shanghai and to explore the relationship between the characteristics and prognosis in these patients.
- Detailed Description
1. To Describe the clinical characteristics of severe and critical COVID-19.
2. To analyze the relationship between the clinical characteristics and their clinical prognosis;
3. To analyze the relationship between clinical intervention and their clinical prognosis.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1000
- severe and critical covid-19 patients who met the "Diagnosis and Treatment Plan for new Coronavirus Pneumonia (Ninth Edition)"
- admission time more than 24 hours
- admission time less than 24 hours
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 28-day mortality one year 28-day mortality of severe and critical COVID-19
- Secondary Outcome Measures
Name Time Method 60-day mortality one year 60-day mortality of severe and critical COVID-19
the percentage of organ failure one year the percentage of organ failure include respiratory，circulatory failure and so on
ICU length of stay one year ICU length of stay
time for virus to turn negative one year time for COVID-19 from positive to negative
The overall description one year The overall description of the clinical characteristics in severe and critical covid-19
Trial Locations
- Locations (1)
Ruijin Hospital
🇨🇳Shanghai, China